Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis

被引:92
|
作者
Barth, H [1 ]
Preiss, JC [1 ]
Hofmann, F [1 ]
Aktories, K [1 ]
机构
[1] Univ Freiburg, Inst Pharmakol & Toxikol, D-79104 Freiburg, Germany
关键词
D O I
10.1074/jbc.273.45.29506
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The actin ADP-ribosylating Clostridium botulinum C2 toxin is a binary toxin composed of the binding component C2II and the enzyme component C2I. C2I ADP-ribosylates G-actin at arginine 177, resulting in the depolymerization of the actin cytoskeleton. Here, we studied the structure-function relationship of C2I by site-directed mutagenesis. Exchange of Glu(389) to glutamine caused the complete loss of ADP-ribosyltransferase and NAD-glycohydrolase activities of C2I. In contrast, exchange of Glu(387) to glutamine blocked ADP-ribosyltransferase but not NAD-glycohydrolase activity. Whereas photoaffinity labeling of the double mutant E387Q/E389Q C2I with [carbonyl-C-14]NAD was blocked, labeling of the single C2I mutants was reduced (E389Q) or not changed (E387Q). Exchange of the STS motif (amino acid residues 348-350) of C2I caused a decrease in transferase activity by more than 99 (S348A) and 90% (T349V), or did not affect activity (S350A). Exchange of Arg(299) and Arg(300) to lysine reduced transferase activity to <0.1 and similar to 35% of wild-type activity. The data indicate that the amino acid residues Glu(389), Glu(387), Ser(348), and Arg(299), which are conserved in various prokaryotic and eukaryotic arginine-modifying ADP-ribosyltransferases, are essential for ADP-ribosyltransferase activity of the enzyme component of C. botulinum C2 toxin.
引用
收藏
页码:29506 / 29511
页数:6
相关论文
共 50 条
  • [1] Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botalinum C2 toxin by site-directed mutagenesis
    Barth, Holger
    Preiss, Jan C.
    Hofmann, Fred
    Aktories, Klaus
    Journal of Biological Chemistry, 1998, 273 (45):
  • [2] CLOSTRIDIUM-BOTULINUM C3 ADP-RIBOSYLTRANSFERASE
    AKTORIES, K
    MOHR, C
    KOCH, G
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1992, 175 : 115 - 131
  • [3] DIFFERENT TYPES OF ADP-RIBOSE PROTEIN BONDS FORMED BY BOTULINUM C2 TOXIN, BOTULINUM ADP-RIBOSYLTRANSFERASE C-3 AND PERTUSSIS TOXIN
    AKTORIES, K
    JUST, I
    ROSENTHAL, W
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) : 361 - 367
  • [4] ALTERATION OF THE CYTOSKELETON OF MAMMALIAN-CELLS CULTURED INVITRO BY CLOSTRIDIUM-BOTULINUM C2 TOXIN AND C3 ADP-RIBOSYLTRANSFERASE
    WIEGERS, W
    JUST, I
    MULLER, H
    HELLWIG, A
    TRAUB, P
    AKTORIES, K
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1991, 54 (02) : 237 - 245
  • [5] CLOSTRIDIUM-BOTULINUM TYPE-C PRODUCES A NOVEL ADP-RIBOSYLTRANSFERASE DISTINCT FROM BOTULINUM-C2 TOXIN
    AKTORIES, K
    WELLER, U
    CHHATWAL, GS
    FEBS LETTERS, 1987, 212 (01) : 109 - 113
  • [6] Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors
    Stevens, LA
    Moss, J
    Vaughan, M
    Pizza, M
    Rappuoli, R
    INFECTION AND IMMUNITY, 1999, 67 (01) : 259 - 265
  • [7] SITE-DIRECTED MUTAGENESIS OF A CATALYTIC ANTIBODY
    STEWART, JD
    ROBERTS, VA
    CROWDER, MW
    GETZOFF, ED
    BENKOVIC, SJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 182 - 182
  • [8] Change of the cosubstrate specificity of Clostridium difficile toxin B by site-directed mutagenesis
    Jank, T
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R47 - R47
  • [9] Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile
    Gülke, I
    Pfeifer, G
    Liese, J
    Fritz, M
    Hofmann, F
    Aktories, K
    Barth, H
    INFECTION AND IMMUNITY, 2001, 69 (10) : 6004 - 6011
  • [10] DETOXIFICATION OF PERTUSSIS TOXIN BY SITE-DIRECTED MUTAGENESIS
    COCKLE, S
    LOOSMORE, S
    RADIKA, K
    ZEALEY, G
    BOUX, H
    PHILLIPS, K
    KLEIN, M
    IMMUNOBIOLOGY OF PROTEINS AND PEPTIDES V : VACCINES: MECHANISMS, DESIGN AND APPLICATIONS, 1989, 251 : 209 - 214